<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Radiotherapy and Oncology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Radiotherapy and Oncology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Radiotherapy+and+Oncology&t=Radiotherapy+and+Oncology&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 03:37:52 +0100</lastBuildDate>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5670026&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814012000382%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670026</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670026</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5669995&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814012000369%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669995</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669995</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5669994&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814012000357%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669994</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669994</guid>        </item>
        <item>
            <title>Locoregional failures following thoracic irradiation in patients with limited-stage small cell lung carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5670013&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007444%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The predominant pattern of LR failure was marginal or out-of-field. LR failures may be preventable with improved radiotherapy target definition. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670013</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670013</guid>        </item>
        <item>
            <title>Radiotherapy in small cell lung cancer: Limited volumes in limited disease and adding thoracic radiotherapy in extended disease?</title>
            <link>http://www.medworm.com/index.php?rid=5669996&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814012000047%2Fabstract%3Frss%3Dyes</link>
            <description>Improving the outcome of treatment of lung cancer remains a formidable and multidisciplinary task . Although distant metastases occur early and frequently in lung cancer it is important to realize that failure to achieve loco-regional control is an equally important reason for todays’ overall poor outcome in this disease . Therefore considerable recent research in the field of radiotherapy has been directed towards technological improvements in target identification by advanced imaging, conformal and motion corrected treatment planning methodologies, more precise as well as better monitored radiotherapy application, and bioimaging for individualized and adaptive treatment approaches . In parallel a large number of retrospective and prospective studies have addressed optimization of total...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669996</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669996</guid>        </item>
        <item>
            <title>Whole-brain irradiation with concomitant daily fixed-dose Temozolomide for brain metastases treatment: A randomised phase II trial</title>
            <link>http://www.medworm.com/index.php?rid=5669999&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007390%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: A daily fixed dose of TMZ during WBI without adjuvant TMZ was well tolerated and significantly improved local control of BM compared with WBI alone. These findings require confirmation in a phase III trial (ClinicalTrials.gov number, NCT01015534). (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669999</comments>
            <pubDate>Wed, 18 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669999</guid>        </item>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5540012&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100733X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540012</comments>
            <pubDate>Sun, 25 Dec 2011 20:44:56 +0100</pubDate>
            <guid isPermaLink="false">5540012</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5539983&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007316%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539983</comments>
            <pubDate>Sun, 25 Dec 2011 20:44:56 +0100</pubDate>
            <guid isPermaLink="false">5539983</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5539982&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007304%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539982</comments>
            <pubDate>Sun, 25 Dec 2011 20:44:56 +0100</pubDate>
            <guid isPermaLink="false">5539982</guid>        </item>
        <item>
            <title>A new lung stent tested as fiducial marker in a porcine model</title>
            <link>http://www.medworm.com/index.php?rid=5670019&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007067%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This new technique based on the Memocore™ lung stent used in connection with respiratory gated radiotherapy was demonstrated to be feasible in a porcine model. The study demonstrated lack of reproducibility in lung trajectories of inserted stents. The technique gave the best accuracy when applied to the exhale phase of respiration. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670019</comments>
            <pubDate>Fri, 23 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670019</guid>        </item>
        <item>
            <title>Feasibility of using anatomical surrogates for predicting the position of lung tumours</title>
            <link>http://www.medworm.com/index.php?rid=5670017&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007080%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: We studied the use of internal anatomical surrogates (carina and diaphragm) for the purpose of predicting the 3D position of lung tumours in 41 patients, in whom repeat 4DCT scans were available. Despite using two surrogates, significant prediction errors were observed, which varied depending on tumour position, baseline tumour motion and respiratory phase. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670017</comments>
            <pubDate>Fri, 23 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670017</guid>        </item>
        <item>
            <title>A dual centre study of setup accuracy for thoracic patients based on Cone-Beam CT data</title>
            <link>http://www.medworm.com/index.php?rid=5670016&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007110%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The setup uncertainties at the two institutions are the same despite different fixation equipments. Hence margins cannot be reduced by changing fixating equipment. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670016</comments>
            <pubDate>Fri, 23 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670016</guid>        </item>
        <item>
            <title>A practical technique to avoid the hippocampus in prophylactic cranial irradiation for lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5670006&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006050%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: A practical technique is presented to deliver hippocampus avoiding prophylactic cranial irradiation for lung cancer patients, using two lateral fields. For a prescribed dose of 12×2.5Gy, sparing of the hippocampi to 6.1Gy was achieved with a V95% of the brain of 81.7%. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670006</comments>
            <pubDate>Thu, 22 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670006</guid>        </item>
        <item>
            <title>Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5539992&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006104%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Higher radiation dose may contribute to the improvement of local control, especially in the field encompassed by IOERT. The addition of IOERT to surgery and adjuvant chemoradiation deserves further investigation in a randomized trial. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539992</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539992</guid>        </item>
        <item>
            <title>Is it time for tailored treatment of rectal cancer? From prescribing by consensus to prescribing by numbers</title>
            <link>http://www.medworm.com/index.php?rid=5539984&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011007109%2Fabstract%3Frss%3Dyes</link>
            <description>In the past two decades a series of multi-institution clinical trials have done much to define the role of multi-modality treatment in the management of rectal adenocarcinoma. These trials have addressed a number of questions about sequencing of modalities, integration of radiation and chemotherapy, and radiation dose fractionation in the adjunctive management of patients undergoing extirpative surgery. Findings from single randomized trials include: (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539984</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539984</guid>        </item>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5444175&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006748%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444175</comments>
            <pubDate>Fri, 25 Nov 2011 20:44:56 +0100</pubDate>
            <guid isPermaLink="false">5444175</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5444143&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006724%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444143</comments>
            <pubDate>Fri, 25 Nov 2011 20:44:56 +0100</pubDate>
            <guid isPermaLink="false">5444143</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5444142&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006712%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444142</comments>
            <pubDate>Fri, 25 Nov 2011 20:44:56 +0100</pubDate>
            <guid isPermaLink="false">5444142</guid>        </item>
        <item>
            <title>Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy – A feasibility and toxicity study</title>
            <link>http://www.medworm.com/index.php?rid=5539998&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100627X%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: Breast cancer sensitivity to large fraction size may be enhanced using hypofractionated concomitant boost radiotherapy (CBRT), thereby shortening overall treatment time. This ethics approved, prospective single cohort feasibility study was designed to evaluate the dosimetry and toxicity of CBRT using an intensity-modulated radiotherapy (IMRT) technique, compared with a standard sequential boost technique (SBT).Methods: Fifteen women (11 right-sided; 4 left-sided) received 42.4Gy to the whole breast and an additional 10.08Gy to the tumor bed in 16 daily fractions, using IMRT and standard dose constraints. Each patient was replanned with the SBT, using mixed photon–electrons. Clinical target volume (CTV), dose evaluation volume (DEV), and organs at risk (OAR) dose dis...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539998</comments>
            <pubDate>Wed, 23 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539998</guid>        </item>
        <item>
            <title>Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: A planning study with clinical implications</title>
            <link>http://www.medworm.com/index.php?rid=5539989&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100630X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Planning results suggest that treatment with protons can improve the therapeutic tolerance for the irradiation of rectal cancer, particularly for patients scheduled for an irradiation with an intensified chemotherapy regimen and identified to be at high risk for acute therapy-related toxicity. However, clinical experiences and long-term observation are needed to assess tumor response and related toxicity rates. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539989</comments>
            <pubDate>Wed, 23 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539989</guid>        </item>
        <item>
            <title>Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors</title>
            <link>http://www.medworm.com/index.php?rid=5670014&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006086%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose/objective(s): IMRT allows dose escalation for large lung tumors, but respiratory motion may compromise delivery. A treatment plan that modulates fluence predominantly in the transversal direction and leaves the fluence identical in the direction of the breathing motion may reduce this problem.Materials/methods: Planning-CT-datasets of 20 patients with Stage I–IV non small cell lung cancer (NSCLC) formed the basis of this study. A total of two IMRT plans and one 3D plan were created for each patient. Prescription dose was 60Gy to the CTV and 70Gy to the GTV. For the 3D plans an energy of 18MV photons was used. IMRT plans were calculated for 6MV photons with 13 coplanar and with 17 noncoplanar beams. Robustness of the used method of anisotropic modulation toward breathing...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670014</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670014</guid>        </item>
        <item>
            <title>Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study</title>
            <link>http://www.medworm.com/index.php?rid=5670010&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006281%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: 18F-FDG PET/CT was specific in N0 staging for T1–2 NSCLC. The NPV was about 91% in clinical N0 patients, suggested that 18F-FDG PET/CT may help to accurately stage N0 patients and thus identify patients for SBRT. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670010</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670010</guid>        </item>
        <item>
            <title>Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study</title>
            <link>http://www.medworm.com/index.php?rid=5670007&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006220%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: Individualised, isotoxic, accelerated radiotherapy (INDAR) allows the delivery of high biological radiation doses, but the long-term survival associated with this approach is unknown.Methods: Patients with stage III NSCLC in the Netherlands Cancer Registry/Limburg from January 1, 2002 to December 31, 2008 were included.Results: Patients (1002) with stage III NSCLC were diagnosed, of which 938 had T4 and/or N2–N3 disease. Patients treated with curative intent were staged with FDG-PET scans and a contrast-enhanced CT or an MRI of the brain. There were no shifts over time in the patient or tumour characteristics at diagnosis. The number of stage III NSCLC patients remained stable over time, but the proportion treated with palliative intent decreased from 47% in 2002 to...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670007</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670007</guid>        </item>
        <item>
            <title>Clinical comparison of positional accuracy and stability between dedicated versus conventional masks for immobilization in cranial stereotactic radiotherapy using 6-degree-of-freedom image guidance system-integrated platform</title>
            <link>http://www.medworm.com/index.php?rid=5670001&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006244%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: To compare the positioning accuracy and stability of two distinct noninvasive immobilization devices, a dedicated (D-) and conventional (C-) mask, and to evaluate the applicability of a 6-degrees-of-freedom (6D) correction, especially to the C-mask, based on our initial experience with cranial stereotactic radiotherapy (SRT) using ExacTrac (ET)/Robotics integrated into the Novalis Tx platform.Materials and methods: The D- and C-masks were the BrainLAB frameless mask system and a general thermoplastic mask used for conventional radiotherapy such as whole brain irradiation, respectively. A total of 148 fractions in 71 patients and 125 fractions in 20 patients were analyzed for the D- and C-masks, respectively. For the C-mask, 3D correction was applied to the initial 10 pat...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670001</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670001</guid>        </item>
        <item>
            <title>Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5540002&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006293%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Our study suggests there might be an association between the TGFβ1 29C&gt;T polymorphism and CVD risk in long-term breast cancer survivors. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540002</comments>
            <pubDate>Mon, 21 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5540002</guid>        </item>
        <item>
            <title>Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5670009&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006268%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We proposed a feature-based approach to evaluate radiation tumor response. Our study demonstrates that multimodality image-feature modeling provides better performance compared to existing metrics and holds promise for individualizing radiotherapy planning. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670009</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670009</guid>        </item>
        <item>
            <title>Electronic portal images (EPIs) based position verification for the breast simultaneous integrated boost (SIB) technique</title>
            <link>http://www.medworm.com/index.php?rid=5540001&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006098%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The described method is superior to using tangential EPIs only and is recommended for position verification of breast cancer patients that are treated with a SIB technique if no Cone beam CT (CBCT) or fiducial markers can be used. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540001</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5540001</guid>        </item>
        <item>
            <title>Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury</title>
            <link>http://www.medworm.com/index.php?rid=5434184&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006360%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Soy isoflavones augment destruction of A549 lung tumor nodules by radiation, and also mitigate vascular damage, inflammation and fibrosis caused by radiation injury to normal lung tissue. Soy could be used as a non-toxic complementary approach to improve RT in NSCLC. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434184</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434184</guid>        </item>
        <item>
            <title>Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series</title>
            <link>http://www.medworm.com/index.php?rid=5434181&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006372%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Postoperative RT with modern techniques is an effective method to obtain excellent local control and cure rates in mesothelioma patients submitted to EPP. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434181</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434181</guid>        </item>
        <item>
            <title>Radiotherapy with curative intent for lung cancer: A continuing success story</title>
            <link>http://www.medworm.com/index.php?rid=5434167&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006323%2Fabstract%3Frss%3Dyes</link>
            <description>Until quite recently, radiotherapy for lung cancer was mostly regarded as a palliative treatment, with only a small role in the curative setting. However, in the last decade, we have witnessed a wealth of clinical trials showing that radiotherapy is an important component in the treatment with curative intent, both for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In stage I NSCLC, many authors have shown that local tumour control rates of approximately 90% can be achieved by either stereotactic ablative radiation therapy (SABR) or high-dose radiotherapy delivered with modern techniques, with only few side effects . These results challenge the view that surgical resection should always be considered to be the first choice therapy for these patients and supports the ...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434167</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434167</guid>        </item>
        <item>
            <title>Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5670012&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006037%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: IFRT based on CT scan in our patients resulted in a low rate of INF (4.6%), all in the ipsilateral supraclavicular area; but another four supraclavicular nodal failures with simultaneously distant metastases were also observed. The modern imaging with higher diagnostic capabilities of lymph node especially for supraclavicular area should be incorporated in the assessment of LS-SCLC when IFRT is being contemplated. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670012</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670012</guid>        </item>
        <item>
            <title>Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5434172&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100538X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Reirradiation with SBRT is feasible although increased risk of toxicity was reported in centrally located tumours. Further research is warranted for more accurate selection of patients suitable for reirradiation with SBRT. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434172</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434172</guid>        </item>
        <item>
            <title>Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: Comparison with a contemporaneous cohort with pathologically proven disease</title>
            <link>http://www.medworm.com/index.php?rid=5434170&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005433%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: As a finding of benign disease is uncommon in Dutch patients undergoing surgery after a clinical diagnosis of stage I NSCLC, patients are also accepted for stereotactic ablative radiotherapy (SABR) without pathology. We studied outcomes in patients who underwent SABR after either a pathological (n=209) or clinical diagnosis (N=382).Materials and methods: Five hundred and ninety-one patients with a single pulmonary lesion underwent SABR after either a pathological- or a clinical diagnosis of stage I NSCLC based on a 18FDG-PET positive lesion with CT features of malignancy. SABR was delivered to a total dose of 60Gy in 3, 5 or 8 fractions, and outcomes were compared between groups with and without pathological diagnosis.Results: Patients with pathology had significant...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434170</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434170</guid>        </item>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5434186&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100658X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434186</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434186</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5434166&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006566%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434166</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434166</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5434165&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006554%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434165</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434165</guid>        </item>
        <item>
            <title>A standardized G2-assay for the prediction of individual radiosensitivity</title>
            <link>http://www.medworm.com/index.php?rid=5391950&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005640%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The standardized G2-assay can minimize inter-laboratory and intra-experimental variations and may have straightforward application in clinical practice for individualization of radiotherapy protocols. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391950</comments>
            <pubDate>Thu, 20 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391950</guid>        </item>
        <item>
            <title>Frontiers in molecular radiation biology/oncology</title>
            <link>http://www.medworm.com/index.php?rid=5391945&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005639%2Fabstract%3Frss%3Dyes</link>
            <description>The understanding of biological contributions to radiation response and their underlying molecular basis has progressed remarkably in recent years. Importantly, the pursuit of a molecular understanding of radiation biology has led not only to an enormous gain in basic knowledge, but also stimulated the implementation of molecular aspects into treatment strategies in radiation oncology. Research areas with the strongest impact on developing new biology-driven treatment strategies in radiotherapy include: (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391945</comments>
            <pubDate>Thu, 20 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391945</guid>        </item>
        <item>
            <title>Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5444154&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005421%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Use of a systematic pain control program may improve compliance with CRT. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444154</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444154</guid>        </item>
        <item>
            <title>Efficacy of routine pre-radiation dental screening and dental follow-up in head and neck oncology patients on intermediate and late radiation effects. A retrospective evaluation</title>
            <link>http://www.medworm.com/index.php?rid=5444153&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005445%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: A worse periodontal condition at dental screening and initial periodontal therapy to safeguard these patients to develop severe oral sequelae after radiotherapy were shown to be major risk factors of developing osteoradionecrosis. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444153</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444153</guid>        </item>
        <item>
            <title>Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice</title>
            <link>http://www.medworm.com/index.php?rid=5391961&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005627%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The effects of radiation-induced atherosclerosis could not be circumvented by these specific anti-inflammatory and anti-coagulant therapies. This suggests that more effective drug combinations may be required to overcome the radiation stimulus, or that other underlying mechanistic pathways are involved compared to age-related atherosclerosis. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391961</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391961</guid>        </item>
        <item>
            <title>Treatment of brain metastases: Review of phase III randomized controlled trials</title>
            <link>http://www.medworm.com/index.php?rid=5669997&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005184%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: The optimal management of brain metastases remains controversial. Both whole brain radiotherapy (WBRT) and local treatment [surgery (S) or radiosurgery (RS)] are the cornerstones of treatment. The role of systemic therapy is also being explored. Randomized controlled trials (RCT) have tried to assess the individual and combined effects of different therapeutic strategies.(1) RCT in oligometastatic patients: WBRT alone vs. local treatment+WBRT. Combined treatment may improve both overall survival and local control in patients with a single metastasis, but it also leads to a local control benefit in patients with two to four lesions.Exclusive local treatment vs. WBRT plus local treatment. The addition of WBRT to local treatment may result in improved local control, improved freedom...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669997</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5669997</guid>        </item>
        <item>
            <title>Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck</title>
            <link>http://www.medworm.com/index.php?rid=5540003&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005366%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: A predictive 15-gene hypoxia classifier could identify patients associated with improved outcome after combining radiotherapy with hypoxic modification and underlines the relevance of such therapy. The impact of the classifier was limited to HPV-negative tumours. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540003</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5540003</guid>        </item>
        <item>
            <title>Node-negative T1–T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?</title>
            <link>http://www.medworm.com/index.php?rid=5539994&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100541X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: In the management of node negative T1–T2 anal cancer, LRC and CSS tend to be superior in patients treated by combined CRT, even though the difference was not significant. Randomized studies are warranted to assess definitively the role of combined treatment in early-stage anal carcinoma. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539994</comments>
            <pubDate>Thu, 13 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539994</guid>        </item>
        <item>
            <title>Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position</title>
            <link>http://www.medworm.com/index.php?rid=5539996&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005342%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Traditional 3DCRT plans provide inadequate nodal coverage. Prone IMRT technique resulted in optimal target coverage and reduced ipsilateral lung V20. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539996</comments>
            <pubDate>Wed, 12 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539996</guid>        </item>
        <item>
            <title>Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience</title>
            <link>http://www.medworm.com/index.php?rid=5670024&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100510X%2Fabstract%3Frss%3Dyes</link>
            <description>We credit Fogliata et al. for reporting the treatment of CSI with VMAT technique. It is worth commenting that VMAT delivers highly conformal radiation in less overall time. The issue of junction matching can be well taken care of at the time of planning. However the volume of lung receiving 5Gy (V5) has not been reported by the above authors. Knowledge of the same is necessary before accepting a newer modality of radiation delivery. V5 of lung is an important criterion which predicts grade 3 or more treatment related pulmonary toxicity. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670024</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670024</guid>        </item>
        <item>
            <title>Radioisotope-antibody conjugates selectively target bone marrow prior to stem cell therapy</title>
            <link>http://www.medworm.com/index.php?rid=5670023&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005202%2Fabstract%3Frss%3Dyes</link>
            <description>In their recent paper, Corvo et al. propose a new concept for intensifying bone marrow dose prior to stem cell transplantation: helical tomotherapy in addition to total body irradiation (TBI) . In a previous study Einsele et al. applied the total marrow irradiation (9Gy) in patients with multiple myeloma . In their study toxicity was relatively high, but the recurrence rate was very low and the event free survival was long. Corvo et al. report no increase in acute side effects, but the incidence of long-term side effects could not be reliably assessed yet due to the relatively short follow-up. Conditioning prior to stem cell transplantation of leukaemia patients is a balancing act between dose escalation to achieve a better cure rate and dose de-escalation to get fewer side effects (so tha...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670023</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670023</guid>        </item>
        <item>
            <title>Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03)</title>
            <link>http://www.medworm.com/index.php?rid=5444173&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100394X%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Randomised controlled trials (RCTs) can be hampered by poor patient accrual and retention. Decision aids (DAs) containing simple, evidence-based information, may assist patients with decision-making regarding trial participation. The current DA was of use for 95% of participants. Further evaluation of the DA in a RCT is currently underway. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444173</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444173</guid>        </item>
        <item>
            <title>Exhaled nitric oxide predicts radiation pneumonitis in esophageal and lung cancer patients receiving thoracic radiation</title>
            <link>http://www.medworm.com/index.php?rid=5444160&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005123%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: Radiation pneumonitis is a significant toxicity following thoracic radiotherapy with no method to predict individual risk.Materials and methods: Sixty-five patients receiving thoracic radiation for lung or esophageal cancer were enrolled in a phase II study. Each patient received respiratory surveys and exhaled nitric oxide measurements before, on the last day of, and 30–60days after completing radiotherapy (RT). Pneumonitis toxicity was scored using the common terminology criteria for adverse events, version 4.0. The demographics, dosimetric factors, and nitric oxide ratio (NOR) of end RT/pre-RT were evaluated for correlation with symptomatic patients (Grade ⩾2).Results: Fifty patients completed the trial. The pneumonitis toxicity score was: Grade 3 f...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444160</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444160</guid>        </item>
        <item>
            <title>Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: A critical re-evaluation including uniform pathologic review</title>
            <link>http://www.medworm.com/index.php?rid=5444157&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005305%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The prognosis of patients with ATC remains grim and our current results appear inferior to those reported previously by our institution. More accurate histologic diagnoses and patient selection in the present series compared to the prior one may be responsible in part. Better therapy is desperately needed for this aggressive disease. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444157</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444157</guid>        </item>
        <item>
            <title>An evaluation of an automated 4D-CT contour propagation tool to define an internal gross tumour volume for lung cancer radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5434183&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005135%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Automated 4D-CT propagation tools can significantly decrease the IGTV delineation time without significantly decreasing the inter- and intra-physician variability. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434183</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434183</guid>        </item>
        <item>
            <title>Prophylactic irradiation of intervention sites in malignant pleural mesothelioma</title>
            <link>http://www.medworm.com/index.php?rid=5434180&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005159%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This study suggests that PIT in mesothelioma reduces the incidence of procedure tract metastasis. Finally, chemotherapy does not seem to have an influence on the incidence of tract metastasis. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434180</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434180</guid>        </item>
        <item>
            <title>Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT</title>
            <link>http://www.medworm.com/index.php?rid=5317945&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005329%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Gated radiotherapy could potentially allow a reduction in PTV volumes from those delineated on all respiratory phases, maintaining acceptable target coverage. Smaller target volumes improve doses distribution in normal tissue especially in the liver and kidney, but also spinal cord and intestine. A significant correlation has been found between dose and volume reduction in the OARs and both GTV motion and PTV volume reduction. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317945</comments>
            <pubDate>Wed, 05 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317945</guid>        </item>
        <item>
            <title>Physics and technology in ESTRO and in Radiotherapy and Oncology: Past, present and into the 4th dimension</title>
            <link>http://www.medworm.com/index.php?rid=5317940&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005408%2Fabstract%3Frss%3Dyes</link>
            <description>‘Those who cannot remember the past are condemned to repeat it’: George Santayana, The Life of Reason, volume 1, 1905‘History is more or less bunk. It’s tradition. We dont want tradition. We want to live in the present’: Henry Ford, interview in the Chicago Tribune, May 25th 1916‘Prediction is difficult, especially about the future’: attributed to Neils Bohr (citing Storm P, Danish comedian and cartoonist) (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317940</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317940</guid>        </item>
        <item>
            <title>Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurements</title>
            <link>http://www.medworm.com/index.php?rid=5670018&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004981%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Changes in breathing motion have been found that emphasize a need for continued position monitoring. RADPOS measurements can be used to monitor such variations as well as to measure surface dose without any disruption to the treatment schedule or discomfort to patients. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670018</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670018</guid>        </item>
        <item>
            <title>Performance of an atlas-based autosegmentation software for delineation of target volumes for radiotherapy of breast and anorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5539995&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005214%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: ABAS produced satisfactory results for these clinical target volumes that are defined by more complex tissue interface geometry, thus streamlining and facilitating the radiotherapy workflow which is essential to face increasing demand and limited resources. STAPLE improved contouring outcome. Small target volumes not clearly defined are still to be delineated manually. Based on these results, ABAS has been clinically introduced for precontouring of CTVs/OARs. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539995</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539995</guid>        </item>
        <item>
            <title>Another form of subgroup to beware</title>
            <link>http://www.medworm.com/index.php?rid=5444174&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005093%2Fabstract%3Frss%3Dyes</link>
            <description>We write to draw readers’ attention to a little recognised form of bias that can influence conclusions which are drawn from the study of patient treatment response subgroups derived after the treatment results become known . We use some of our own data to illustrate the issue. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444174</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444174</guid>        </item>
        <item>
            <title>Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT &amp; Arc technique for esophageal carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5444158&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100507X%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: To compare radiotherapy treatment plans for mid- and distal-esophageal cancer with primary involvement of the gastroesophageal (GE) junction using a novel IMRT &amp; Arc technique (IMRT &amp; Arc), helical tomotherapy (HT), and RapidArc (RA1 and RA2).Methods and materials: Eight patients treated on HT for locally advanced esophageal cancer with radical intent were re-planned for RA and IMRT&amp;Arc. RA plans employed single and double arcs (RA1 and RA2, respectively), while IMRT&amp;Arc plans had four fixed-gantry IMRT fields and a conformal arc. Dose-volume histogram statistics, dose uniformity, and dose homogeneity were analyzed to compare treatment plans.Results: RA2 plans showed significant improvement over RA1 plans in terms of OAR dose and PTV dose uniformity and homogeneity. HT p...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444158</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444158</guid>        </item>
        <item>
            <title>A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT</title>
            <link>http://www.medworm.com/index.php?rid=5444151&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005007%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: All treatment paradigms produced plans of excellent quality and dosimetric accuracy with IMRT providing best OAR sparing and VMAT being the most efficient treatment option in our comparison of treatment plans with high complexity. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444151</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444151</guid>        </item>
        <item>
            <title>Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al2O3:C dosimetry and a novel statistical error decision criterion</title>
            <link>http://www.medworm.com/index.php?rid=5317963&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005354%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: This phantom study demonstrates that Al2O3:C real-time dosimetry can identify applicator displacements ⩾5mm and interchanged guide tube errors during PDR and HDR brachytherapy. The study demonstrates the shortcoming of a constant error criterion and the advantage of a statistical error criterion. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317963</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317963</guid>        </item>
        <item>
            <title>Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT</title>
            <link>http://www.medworm.com/index.php?rid=5317961&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005330%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Agreement of COMPASS QA results with film based QA supports its clinical introduction for a phantom geometry. A standard MLC calibration check is sensitive to (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317961</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317961</guid>        </item>
        <item>
            <title>Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer</title>
            <link>http://www.medworm.com/index.php?rid=5317959&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005317%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: The aim was to evaluate the impact of a spacer gel on the dose distribution, applying three-dimensional conformal (3D CRT) and intensity modulated radiotherapy (IMRT) planning techniques.Material and methods: The injection of a spacer gel (10ml SpaceOAR™) was performed between the prostate and rectum under transrectal ultrasound guidance in 18 patients with prostate cancer. 3D CRT and IMRT treatment plans were compared based on CT before and after injection (78Gy prescription dose).Results: In contrast to the PTV and bladder, significant advantages (p50% for both IMRT and 3D CRT. Significantly (p (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317959</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317959</guid>        </item>
        <item>
            <title>Determination of the correction factors for different ionization chambers used for the calibration of the helical tomotherapy static beam</title>
            <link>http://www.medworm.com/index.php?rid=5317957&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005226%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Direct calibration of ICs versus radiochromic films provided correction factors equivalent to those obtained following the TG-148 formalism. This study showed that ICs calibrated for conventional linear accelerators can be used for the calibration of the static beam delivered by a HT unit taking into account the particular reference conditions. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317957</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317957</guid>        </item>
        <item>
            <title>Functional avoidance of lung in plan optimization with an aperture-based inverse planning system</title>
            <link>http://www.medworm.com/index.php?rid=5317951&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005287%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Angle optimization and SPECT-based modulation of importance factors allowed for functional avoidance of the lung while preserving target coverage. The technique could be also applied to implement PET-based modulation inside the target volume, leading to a safer dose escalation. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317951</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317951</guid>        </item>
        <item>
            <title>4D-CBCT reconstruction using MV portal imaging during volumetric modulated arc therapy</title>
            <link>http://www.medworm.com/index.php?rid=5317949&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005263%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The visibility of the anatomy in 4D VMAT-CBCT reconstruction for lung cancer patients has the potential of using 4D VMAT-CBCT as a tool for verifying relative positions of tumour for each respiratory phase. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317949</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317949</guid>        </item>
        <item>
            <title>Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5317941&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005378%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Brachytherapy has consistently provided a very conformal radiation therapy modality. Over the last two decades this has been associated with significant improvements in imaging for brachytherapy applications (prostate, gynecology), resulting in many positive advances in treatment planning, application techniques and clinical outcome. This is emphasized by the increased use of brachytherapy in Europe with gynecology as continuous basis and prostate and breast as more recently growing fields. Image guidance enables exact knowledge of the applicator together with improved visualization of tumor and target volumes as well as of organs at risk providing the basis for very individualized 3D and 4D treatment planning.In this commentary the most important recent developments in prostate,...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317941</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317941</guid>        </item>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5391983&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005950%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391983</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391983</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5391944&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005937%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391944</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391944</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5391943&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011006311%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391943</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391943</guid>        </item>
        <item>
            <title>An analytical approach to acceptance criteria for quality assurance of intensity modulated radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5317962&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005238%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Detectability and impact of potential treatment machine errors on IMRT treatments were evaluated. The ability of the gamma index to detect deliberately introduced errors was assessed and their clinical impact was assessed using Tumour Control Probability (TCP) and Normal Tissue Complication Probability. TCP was only marginally affected by 2mm errors in MLC position. Dose delivery errors had greater impact but were not detected as effectively using the gamma index. Acceptance criteria should include mean dose as well as gamma to help identify errors in the delivered dose. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317962</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317962</guid>        </item>
        <item>
            <title>Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: Practical implications of using a broad or sharp brush</title>
            <link>http://www.medworm.com/index.php?rid=5317952&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005299%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Both large brush DPBC and sharp brush DPBN techniques can be used to considerably boost the dose to the FDG avid regions. However, significantly higher boost levels can be obtained using sharp brush DPBN although sometimes at the cost of a less increased dose to the low SUV regions. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317952</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317952</guid>        </item>
        <item>
            <title>The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5317942&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005251%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: MDE may not always be eradicated by the beam penumbra or existing PTV margins using either 3D conformal or stereotactic radiotherapy. Nonetheless, TCP modeling indicates an overall local control rate above 90% for the stereotactic technique, while a non-zero CTV margin is recommended for better local control of MDE when using the 3D conformal technique. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317942</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317942</guid>        </item>
        <item>
            <title>Experimental small field 6MV output ratio analysis for various diode detector and accelerator combinations</title>
            <link>http://www.medworm.com/index.php?rid=5317958&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005275%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Experimental small field ORdet measured with the diode detectors used in this study are reproducible to within ±1.25% (standard uncertainty), with the precision of any one set of measurements can be characterized with a CV between 0.10% and 0.15%. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317958</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317958</guid>        </item>
        <item>
            <title>Radiation therapy with unflattened photon beams: Dosimetric accuracy of advanced dose calculation algorithms</title>
            <link>http://www.medworm.com/index.php?rid=5317956&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100524X%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: To compare the dosimetric accuracy of advanced dose calculation algorithms for flattened (FF) and unflattened (FFF) photon beams.Material and methods: We compared the enhanced collapsed cone (eCC) algorithm implemented in OncentraMasterplan and the XVMC (MC) code in Monaco. Test plans were created for 10MV FF and FFF beams. Single beam tests were delivered to radiochromic films positioned within a solid water phantom and evaluated with 1D γ-index analysis. Conformal plans were verified with ion chambers in an anthropomorphic thorax phantom. IMRT plans were applied to the Delta4 system and evaluated with γ-criteria of 3% and 3mm.Results: 1D γ-index evaluation revealed significantly lower (p (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317956</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317956</guid>        </item>
        <item>
            <title>Reply to the Letter to the editor on Cranio-spinal irradiation with volumetric modulated arc therapy by G. Saini et al.</title>
            <link>http://www.medworm.com/index.php?rid=5670025&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005111%2Fabstract%3Frss%3Dyes</link>
            <description>The authors thank Dr. Gagan Saini and coworkers for their astute comments on cranio-spinal irradiation (CSI) treatment using Volumetric Modulated Arc Therapy (VMAT). Indeed no data related to V5Gy for lungs were reported in our paper on CSI , this metric being a reported predictor for radiation induction pneumonitis. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670025</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670025</guid>        </item>
        <item>
            <title>Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy</title>
            <link>http://www.medworm.com/index.php?rid=5434174&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005160%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The CG/GG genotypes of HSPB1 rs2868371 were associated with lower risk of RIET, compared with the CC genotype in patients with NSCLC treated with radio(chemo)therapy. This finding should be validated in large multi-institutional prospective trials. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434174</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434174</guid>        </item>
        <item>
            <title>Dealing with geometric uncertainties in dose painting by numbers: Introducing the ΔVH1</title>
            <link>http://www.medworm.com/index.php?rid=5317953&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005056%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Clinical treatment planning tools were extended to allow non-uniform prescription. For planning we introduced confidence level based probabilistic optimization with non-uniform target dose, while confidence levels of ΔVH points summarize the probability of proper target coverage. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317953</comments>
            <pubDate>Wed, 21 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317953</guid>        </item>
        <item>
            <title>Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5670008&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005196%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Post-chemotherapy consolidation chest RT for ES-SCLC patients on this trial was well tolerated and associated with symptomatic chest recurrences in only 5/32 treated patients. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670008</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670008</guid>        </item>
        <item>
            <title>Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=5434182&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005172%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: LA-V25, LV- and RV-V30 prove to be predictors of asymptomatic alteration of valve functionality. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434182</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434182</guid>        </item>
        <item>
            <title>Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy</title>
            <link>http://www.medworm.com/index.php?rid=5317967&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005019%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: To evaluate the feasibility of supine breast magnetic resonance imaging (MR) for definition and localization of the surgical bed (SB) after breast conservative surgery. To assess the inter-observer variability of surgical bed delineation on computed tomography (CT) and supine MR.Materials and methods: Patients candidate for breast brachytherapy and no contra-indications for MR were eligible for this study. Patients were placed in supine position, with the ipsilateral arm above the head in an immobilization device. All patients underwent CT and MR in the same implant/treatment position. Four points were predefined for CT-MRI image fusion. The surgical cavity was drawn on CT then MRI, by three independent observers. Fusion and analysis of CT and MR images were performed us...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317967</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317967</guid>        </item>
        <item>
            <title>Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept</title>
            <link>http://www.medworm.com/index.php?rid=5317966&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004932%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Image and laparoscopic guided interstitial PDR-BT using the GEC ESTRO target concept is applicable for locally advanced primary vaginal or recurrent endometrial and cervical cancer resulting in an excellent local control rate and limited morbidity. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317966</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317966</guid>        </item>
        <item>
            <title>Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched-pair analysis</title>
            <link>http://www.medworm.com/index.php?rid=5317965&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004828%2Fabstract%3Frss%3Dyes</link>
            <description>This study examines the dose distribution within the HR CTV and intermediate (IR) CTV in patients with cervical cancer treated with definitive EBRT +/− concomitant chemotherapy and MRI-based IGABT between patients with local recurrence (LR) and patients in continuous complete local remission (CCLR).Material and methods: From 1998 to 2010, 265 patients were treated with definitive EBRT +/− concomitant chemotherapy and IGABT. Twenty-four LRs were documented. For the statistical analysis all patients with LR were matched to patients in CCLR from our database according to the following criteria: FIGO stage, histology, lymph node status, tumour size and chemotherapy.DVH parameters (D50, D90, D98, D100) were reported for HR CTV and IR CTV. In order to report the minimum dose in the region wh...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317965</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317965</guid>        </item>
        <item>
            <title>Is single fraction 15Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5317964&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004993%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The Single Fraction HDR protocol results in high disease control rate and low toxicity similar to our previous protocol using two HDR insertions, with significant savings in resources. While mature results with longer follow-up are awaited, a single 15Gy may be considered as a standard fractionation regimen in combination with EBRT for men with intermediate risk disease. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317964</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317964</guid>        </item>
        <item>
            <title>Realisation of the absorbed dose to water for I-125 interstitial brachytherapy sources</title>
            <link>http://www.medworm.com/index.php?rid=5317960&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005020%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: A large air-filled parallel-plate extrapolation chamber in a phantom of water-equivalent material is used as a primary standard measuring device for low-energy interstitial brachytherapy sources from which the unit of absorbed dose to water can be derived. The chamber is suitable for low-energy photons with energies up to 50keV. The method to determine the absorbed dose to water was newly developed based on radiation transport theory. It offers a clear analytical expression to determine Dw. A conversion factor C(xi,xi+1) has to be applied to the difference of ionization charges measured at two plate separations xi and xi+1.The details of the method are presented. The determination of Dw of an I-125 seed is demonstrated by the measurement of a ‘BEBIG Symmetra I25.S16’ – seed...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317960</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317960</guid>        </item>
        <item>
            <title>Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy</title>
            <link>http://www.medworm.com/index.php?rid=5317955&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005032%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This work suggests that GNP radiosensitisation is driven by inhomogeneities in dose on the nanoscale, rather than changes in dose over the entire cell, which may contribute to the similar radiosensitisation observed in megavoltage and kilovoltage experiments. The short range of these inhomogeneities and the variation in enhancement in different cells suggests sub-cellular localisation is important in determining GNP radiosensitisation. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317955</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317955</guid>        </item>
        <item>
            <title>A coverage probability based method to estimate patient-specific small bowel planning volumes for use in radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5317954&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005147%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Based on a few CTs, our method generates patient-specific SB PRVs which are both sensitive and specific. Compared to conventional approaches, the patient-specific PRVs are either similar or better in predicting for SB voxels, and at the same time they occupy a smaller or similar volume in the patient. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317954</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317954</guid>        </item>
        <item>
            <title>MRI to quantify early radiation-induced changes in the salivary glands</title>
            <link>http://www.medworm.com/index.php?rid=5317950&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100497X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Overall radiation-induced changes and volume loss were observed in the parotid and submandibular gland using MR. The observed differences indicated an increased water content such as found in oedema. The overall changes could be related to the mean dose, with a slightly greater impact in the high dose area. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317950</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317950</guid>        </item>
        <item>
            <title>Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: Experiments and a simulation model</title>
            <link>http://www.medworm.com/index.php?rid=5317948&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005068%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: A clinical DECT scanner was able to extract Z and ρe of tissue substitutes. Our simulation tool replicates the experiments within a reasonable accuracy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317948</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317948</guid>        </item>
        <item>
            <title>Development of an online adaptive solution to account for inter- and intra-fractional variations</title>
            <link>http://www.medworm.com/index.php?rid=5317947&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005044%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The online adaptive replanning technique based on daily respiration-gated diagnostic-quality CT combined with gated delivery can effectively correct for inter- and intra-fraction variations during radiation therapy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317947</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317947</guid>        </item>
        <item>
            <title>A novel method for megavoltage scatter correction in cone-beam CT acquired concurrent with rotational irradiation</title>
            <link>http://www.medworm.com/index.php?rid=5317946&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004968%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: A novel, efficient and effective method was developed to correct for MV scatter in CBCT scans acquired concurrent with rotational radiotherapy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317946</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317946</guid>        </item>
        <item>
            <title>Comparative study of respiratory motion correction techniques in cone-beam computed tomography</title>
            <link>http://www.medworm.com/index.php?rid=5317944&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004956%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: To validate the clinical usefulness of motion-compensated (MC) cone-beam (CB) computed tomography (CT) for image-guided radiotherapy (IGRT) in comparison to four-dimensional (4D) CBCT and three-dimensional (3D) CBCT.Material and methods: Forty-eight stereotactic body radiation therapy (SBRT) patients were selected. Each patient had 5–12 long CB acquisitions (4min) and 1–7 short CB acquisitions (1min), with a total of 349 and 150 acquisitions, respectively. 3D, 4D and MC CBCT images of every acquisition were reconstructed. Image quality, tumor positioning accuracy and tumor motion amplitude were quantified.Results: The mean image quality of long short acquisitions, measured using the correlation ratio with the planning CT, was 74%/70%, 67%/47% and 79%/7...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317944</comments>
            <pubDate>Mon, 19 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317944</guid>        </item>
        <item>
            <title>The quality of radiation care: The results of focus group interviews and concept mapping to explore the patient’s perspective</title>
            <link>http://www.medworm.com/index.php?rid=5540008&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004464%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The quality aspects found through focus group discussions provided useful insight into how patients experience radiation care. Furthermore, concept mapping made these results more solid. To evaluate the quality of radiation care from the patient’s perspective, these quality aspects will be guiding in the development of a CQI Radiation Care. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540008</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5540008</guid>        </item>
        <item>
            <title>Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: Alternative to mastectomy? Results from a prospective trial</title>
            <link>http://www.medworm.com/index.php?rid=5539999&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003987%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Accelerated PDR-brachytherapy following breast conserving surgery (BCS) for local IBTR results in local tumour control comparable to mastectomy. Morbidity is moderate; the cosmetic outcome is good and hardly any impairment on QoL is observed. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539999</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539999</guid>        </item>
        <item>
            <title>Preoperative radio-chemotherapy in early breast cancer patients: Long-term results of a phase II trial</title>
            <link>http://www.medworm.com/index.php?rid=5539997&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004944%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Preoperative concurrent administration of RT and CT is an effective regimen. Long-term toxicity is moderate. This association deserves further evaluations in prospective trials. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539997</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539997</guid>        </item>
        <item>
            <title>Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5444159&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003938%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: To compare the effectiveness of tomotherapy and three-dimensional (3D) conformal radiotherapy to spare normal critical structures (spinal cord, lungs, and ventricles) from excessive radiation in patients with distal esophageal cancers.Materials and methods: A retrospective dosimetric study of nine patients who had advanced gastro-esophageal (GE) junction cancer (7) or thoracic esophageal cancer (2) extending into the distal esophagus. Two plans were created for each of the patients. A three-dimensional plan was constructed with either three (anteroposterior, right posterior oblique, and left posterior oblique) or four (right anterior oblique, left anterior oblique, right posterior oblique, and left posterior oblique) fields. The second plan was for tomotherapy. Doses wer...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444159</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444159</guid>        </item>
        <item>
            <title>The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer – A planning study</title>
            <link>http://www.medworm.com/index.php?rid=5434178&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100483X%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: To compare the dosimetric performance of three different treatment techniques – conformal radiotherapy (CRT), double arcs volumetric modulated arc therapy (RapidArc, RA) and Hybrid-RapidArc (H-RA) for locally-advanced non-small cell lung cancer (NSCLC).Material and methods: CRT, RA and H-RA plans were optimized for 24 stage III NSCLC patients. The target prescription dose was 60Gy. CRT consisted of 5–7 coplanar fields, while RA comprised of two 204o arcs. H-RA referred to two 204o arcs plus 2 static fields, which accounted for approximately half of the total dose. The plans were optimized to fulfill the departmental plan acceptance criteria.Results: RA and H-RA yielded a 20% better conformity compared with CRT. Lung volume receiving &gt;20Gy (V20) and mean lung dose (ML...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434178</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434178</guid>        </item>
        <item>
            <title>Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands</title>
            <link>http://www.medworm.com/index.php?rid=5539987&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004786%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: The aim of this study was to measure and improve the quality of target volume delineation by means of national consensus on target volume definition in early-stage rectal cancer.Methods and materials: The CTV’s for eight patients were delineated by 11 radiation oncologists in 10 institutes according to local guidelines (phase 1). After observer variation analysis a workshop was organized to establish delineation guidelines and a digital atlas, with which the same observers re-delineated the dataset (phase 2). Variation in volume, most caudal and cranial slice and local surface distance variation were analyzed.Results: The average delineated CTV volume decreased from 620 to 460cc (p (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539987</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539987</guid>        </item>
        <item>
            <title>Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: A phase II trial</title>
            <link>http://www.medworm.com/index.php?rid=5539985&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004087%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The design of preoperative concurrent boost IMRT with oral capecitabine could achieve high rate of ypCR with an acceptable toxicity profile. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539985</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539985</guid>        </item>
        <item>
            <title>Can diet combined with treatment scheduling achieve consistency of rectal filling in patients receiving radiotherapy to the prostate?</title>
            <link>http://www.medworm.com/index.php?rid=5444165&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004440%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Patient self reporting of bowel motion, fibre, fluid intake was achievable but consistency of rectal filling was not improved. Improved understanding of the aetiology and management of rectal gas is indicated. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444165</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444165</guid>        </item>
        <item>
            <title>The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination</title>
            <link>http://www.medworm.com/index.php?rid=5391955&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004804%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Amuvatinib is a promising agent that may be used to decrease tumor cell resistance. Our work suggests that this is associated with decreased RAD51 expression and function and supports the further study of amuvatinib in combination with chemotherapy and radiotherapy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391955</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391955</guid>        </item>
        <item>
            <title>Radiation dose response of normal lung assessed by Cone Beam CT – A potential tool for biologically adaptive radiation therapy</title>
            <link>http://www.medworm.com/index.php?rid=5317943&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004798%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: CBCT density changes in healthy lung tissue during radiotherapy correlate with the locally delivered dose and can be detected relatively early during the treatment. If these density changes are correlated to subsequent clinical toxicity this assay could form the basis for biological adaptive radiotherapy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317943</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317943</guid>        </item>
        <item>
            <title>Oncologists’ view of informed consent and shared decision making in paediatric radiation oncology</title>
            <link>http://www.medworm.com/index.php?rid=5670003&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004063%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The majority of oncologists who treat children believe discussing late effects with parents is important. However, there is mixed opinion on which late effects should be discussed and whether parents should be involved in deciding which treatments should be pursued. Research into perceived barriers to shared decision making and effective methods of improving the informed consent process in paediatric malignancies is needed. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670003</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670003</guid>        </item>
        <item>
            <title>Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer</title>
            <link>http://www.medworm.com/index.php?rid=5444171&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004002%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: It is widely believed that younger prostate cancer patients are at greater risk of recurrence following radiotherapy (RT).Methods: From 1992 to 2007, 2168 (395 age ⩽60) men received conformal RT alone for prostate cancer at our institution (median dose=76Gy, range: 72–80). Multivariable analysis (MVA) was used to identify significant predictors for BF and PCSM. Cumulative incidence was estimated using the competing risk method (Fine and Gray) for BF (Phoenix definition) and PCSM to account for the competing risk of death.Results: With a median follow-up of 72.2months (range: 24.0–205.1), 8-year BF was 27.1% for age ⩽60 vs. 23.7% for age &gt;60 (p=0.29). Eight-year PCSM was 3.0% for age ⩽60 vs. 2.0% for age &gt;60 (p=0.52). MVA for BF identified initial PSA [adjust...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444171</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444171</guid>        </item>
        <item>
            <title>Prostate HDR brachytherapy catheter displacement between planning and treatment delivery</title>
            <link>http://www.medworm.com/index.php?rid=5444168&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004452%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Catheter displacement can occur in the 1–3h between the planning CT scan and treatment. It is recommended that departments performing HDR prostate brachytherapy verify catheter positions immediately prior to treatment delivery. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444168</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444168</guid>        </item>
        <item>
            <title>The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)</title>
            <link>http://www.medworm.com/index.php?rid=5434177&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004580%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: The maximum standardized uptake value (SUVmax) of FDG-PET may predict local recurrence for localized non-small-cell lung cancer (NSCLC) after stereotactic body radiotherapy (SBRT).Methods: Among 195 localized NSCLCs that were treated with total doses of either 40Gy or 50Gy in 5 SBRT fractions, we reviewed those patients who underwent pre-treatment FDG-PET using a single scanner for staging. Local control rates (LCRs) were obtained by the Kaplan–Meier method and a log-rank test. Prognostic significance was assessed by univariate and multivariate analyses.Results: A total of 95 patients with 97 lesions were eligible. Median follow-up was 16.0months (range: 6.0–46.3months). Local recurrences occurred in 9 lesions. By multivariate analysis, only the SUVmax of a primar...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434177</comments>
            <pubDate>Fri, 02 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434177</guid>        </item>
        <item>
            <title>External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5670020&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003999%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Curatively intended radiotherapy alone can be offered to esophageal cancer patients, even when surgery and/or chemotherapy are not feasible. However, we observed severe toxicity in a substantial part of the patients. Given the relatively high rate of severe complications and the uncertainties regarding dose escalation, the addition of brachytherapy, with consequently high surface doses, should be limited to well-selected patients. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670020</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670020</guid>        </item>
        <item>
            <title>Monitoring tumor motion by real time 2D/3D registration during radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5670015&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004099%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We have demonstrated that real-time organ motion monitoring using image based markerless registration is feasible. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670015</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670015</guid>        </item>
        <item>
            <title>Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)</title>
            <link>http://www.medworm.com/index.php?rid=5670011&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004014%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: FDG-PET images can be analysed during thoracic RT, given either alone or with chemotherapy, without disturbing radiation-induced artefacts. An average 50% decrease in SUVmax was observed around 40–45Gy (i.e., during week 5 of RT). The three delineation methods yielded consistent volume measurements before RT and during the first week of RT, while manual delineation appeared to be more reliable later on during RT. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670011</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670011</guid>        </item>
        <item>
            <title>Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix</title>
            <link>http://www.medworm.com/index.php?rid=5540004&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004427%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: Trans-abdominal ultrasonography (US) is capable of determining size, shape, thickness, and diameter of uterus, cervix and disease at cervix or parametria. To assess the potential value of US for image-guided cervical cancer brachytherapy, we compared US-findings relevant for brachytherapy to the corresponding findings obtained from MR imaging.Materials and methods: Twenty patients with biopsy proven cervical cancer undergoing definitive radiotherapy with/without concomitant Cisplatin chemotherapy and suitable for brachytherapy were invited to participate in this study. US and MR were performed in a similar reproducible patient positioning after intracavitary application. US mid-sagittal and axial image at the level of external cervical os was acquired. Reference points D...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540004</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5540004</guid>        </item>
        <item>
            <title>Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET</title>
            <link>http://www.medworm.com/index.php?rid=5539991&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004476%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The repeated cycles of PRRT did not cause a clinically significant increase of the toxicity of PRRT. The changes in kidney and blood morphology parameters were transient. The repeated cycles of PRRT enabled stabilization of the disease. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539991</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539991</guid>        </item>
        <item>
            <title>18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer</title>
            <link>http://www.medworm.com/index.php?rid=5444147&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004038%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: GTVp-CT was significantly larger when compared to GTVp-PET. No such change was observed for the lymph nodes. 18F-FDG-PET modified treatment management in three patients, including two for which no curative radiotherapy was attempted. Larger multicenter studies are needed to ascertain whether combined 18F-FDG-PET/CT in target delineation can influence the main clinical outcomes. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444147</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444147</guid>        </item>
        <item>
            <title>Expression of Wnt-1, TGF-β and related cell–cell adhesion components following radiotherapy in salivary glands of patients with manifested radiogenic xerostomia</title>
            <link>http://www.medworm.com/index.php?rid=5391960&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100418X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Increased transdifferentiation and remodeling of acinar structures was associated with decrease of viable acinar structures. The role of Wnt and TGF signaling may provide a potential therapeutic approach to prevent radiation-induced damage to salivary glands during radiotherapy for head and neck cancer. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391960</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391960</guid>        </item>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5317968&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005585%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317968</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317968</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5317939&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011005561%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317939</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317939</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5317938&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100555X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317938</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5317938</guid>        </item>
        <item>
            <title>Reirradiation of brain metastases with radiosurgery</title>
            <link>http://www.medworm.com/index.php?rid=5670000&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003963%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Reirradiation of BM with SRS resulted feasible and effective. A correct patient selection and an accurate evaluation of the cumulative irradiation dose were suggested. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670000</comments>
            <pubDate>Wed, 31 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670000</guid>        </item>
        <item>
            <title>Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5670021&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004051%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Substantial residual setup errors would occur for treatment fractions without IG even if the most frequent less-than-daily IG strategy was to be used, which could lead to significant daily dose variations for the target volume and adjacent normal tissues. Daily image guidance is recommended throughout the course of treatment in conformal radiotherapy for esophageal cancer. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670021</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670021</guid>        </item>
        <item>
            <title>The cost of radiotherapy in a decade of technology evolution</title>
            <link>http://www.medworm.com/index.php?rid=5540007&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004191%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The ABC model provides insight into the financial consequences of evolving technology and practice. Such data are a mandatory first step in our strive to prove RT cost-effectiveness and thus support optimal reimbursement and provision of radiotherapy departments. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5540007</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5540007</guid>        </item>
        <item>
            <title>Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5444164&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003975%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: ERB application significantly reduces Awall and to a lesser degree Rwall doses in high-dose post-prostatectomy IMRT. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444164</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444164</guid>        </item>
        <item>
            <title>Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low–intermediate and high risk patients</title>
            <link>http://www.medworm.com/index.php?rid=5444162&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003951%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: To report the long-term biochemical control of a non-randomized trial comparing standard (STD) and hyper-fractionated (HFX) radiation schedules for prostate cancer treatment.Materials and methods: Between 1993 and 2003, 370 patients entered the study; 330/370 (STD: 179; HFX: 151) were evaluable for current analysis. Median doses were 79.2Gy and 74Gy for HFX (1.2Gy/fr, two daily fractions) and STD (2Gy/fr), respectively; median follow-up was 7.5yr. The two regimens were compared in terms of biochemical relapse-free survival (according to ASTRO definition, bRFS) by univariate (log-rank test) and multivariate analyses (Cox regression hazard model). Based on published relationships between EQD2 and 5-yr biochemical control, α/β values for each subgroup could...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444162</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444162</guid>        </item>
        <item>
            <title>Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance</title>
            <link>http://www.medworm.com/index.php?rid=5444148&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004075%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Combined FMISO-PET imaging and IMRT planning permit delivery of higher doses to hypoxic regions, increasing the predicted TCP (mean 17%) without increasing expected complications. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444148</comments>
            <pubDate>Mon, 29 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444148</guid>        </item>
        <item>
            <title>Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results</title>
            <link>http://www.medworm.com/index.php?rid=5670005&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003793%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: fSRT is an effective treatment modality for uveal melanoma with a good local control. With that, fSRT is a serious eye sparing treatment modality. However, our FU is relatively short. Also, the number of secondary enucleations is substantial, mainly caused by NVG. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670005</comments>
            <pubDate>Wed, 24 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670005</guid>        </item>
        <item>
            <title>Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone</title>
            <link>http://www.medworm.com/index.php?rid=5444167&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003811%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: HyRT to a dose of 66Gy in 22 fractions as a single treatment modality is convenient for patients and for the health care system and appears to provide similar results to other treatment choices. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444167</comments>
            <pubDate>Wed, 24 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444167</guid>        </item>
        <item>
            <title>The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5444166&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003914%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Automatic contractions from the outer surface provide quicker, more reproducible and reasonably accurate substitutes for BW_m. The widespread use of automatic contractions to create a bladder wall volume would assist in the consistent application of IMRT dose constraints and the interpretation of reported dose. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444166</comments>
            <pubDate>Wed, 24 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444166</guid>        </item>
        <item>
            <title>Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5444163&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003902%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: Assessing predictors of acute bowel toxicity after whole-pelvis irradiation (WPRT) Image-guided Tomotherapy with simultaneous integrated boost on prostate/prostate bed.Methods and materials: In the period March 2005–April 2009, 178 patients were treated with radical or adjuvant/salvage intent with WPRT Tomotherapy. Median dose to the pelvic nodes was 51.8Gy/28 fractions while concomitantly delivering 65.5–74.2Gy to prostate/prostatic bed. The impact of many anatomical and clinical parameters on ⩾Grade 2 acute bowel toxicity was investigated by logistic analyses.Results: Only 15/178 patients (8.4%) experienced Grade 2 toxicity (none Grade 3). Main predictors at univariate analysis were nodal CTV (CTVN⩾380cc; OR: 3.7, p=0.017), treatment duration ( (Source: Radioth...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5444163</comments>
            <pubDate>Wed, 24 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5444163</guid>        </item>
        <item>
            <title>Helical tomotherapy for resected malignant pleural mesothelioma: Dosimetric evaluation and toxicity</title>
            <link>http://www.medworm.com/index.php?rid=5434179&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003926%2Fabstract%3Frss%3Dyes</link>
            <description>This study evaluated adjuvant helical tomotherapy after extrapleural pneumonectomy±neo-adjuvant chemotherapy in 24 patients with malignant pleural mesothelioma. Toxicity was judged acceptable despite 2 cases (8%) of suspected grade 5 pneumonitis. With a mean follow-up of 7months, 5 patients had distant and 2 local and distant failure. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434179</comments>
            <pubDate>Wed, 24 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434179</guid>        </item>
        <item>
            <title>TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells</title>
            <link>http://www.medworm.com/index.php?rid=5391966&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100377X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: TIGAR abrogation provides a novel adjunctive therapeutic strategy against glial tumors by increasing radiation-induced cell impairment, thus allowing the use of lower radiotherapeutic doses. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391966</comments>
            <pubDate>Wed, 24 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391966</guid>        </item>
        <item>
            <title>A prospective study of supine versus prone positioning and whole-body thermoplastic mask fixation for craniospinal radiotherapy in adult patients</title>
            <link>http://www.medworm.com/index.php?rid=5670004&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003781%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The more comfortable supine position is recommended for craniospinal irradiation in adult patients. Whole-body thermoplastic mask immobilization provides excellent repositioning accuracy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5670004</comments>
            <pubDate>Mon, 22 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5670004</guid>        </item>
        <item>
            <title>Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5391954&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003768%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Nuclear accumulation of Survivin and interaction with components of the DNA-double-strand break (DSB) repair machinery indicates Survivin to regulate DSB damage repair that leads to a significant improvement of survival of LN229 glioblastoma cells. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391954</comments>
            <pubDate>Fri, 19 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391954</guid>        </item>
        <item>
            <title>Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: A prospective randomized controlled multi-center trial</title>
            <link>http://www.medworm.com/index.php?rid=5187196&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003835%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Patients received standard adjuvant chemotherapy plus radiation therapy was more effective than chemotherapy alone in women with triple-negative early-stage breast cancer after mastectomy. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187196</comments>
            <pubDate>Wed, 17 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5187196</guid>        </item>
        <item>
            <title>Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging</title>
            <link>http://www.medworm.com/index.php?rid=5391979&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003756%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Information on both the extent of hypoxia and the level of interstitial hypertension in A-07 tumors can be derived from a single DCE-MRI series by using gadomelitol as contrast agent. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391979</comments>
            <pubDate>Tue, 16 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391979</guid>        </item>
        <item>
            <title>Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5391952&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003859%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Constitutive γ-H2AX and 53BP1 staining reveals a subset of patients with triple negative breast tumors that have a significantly poorer prognosis. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391952</comments>
            <pubDate>Tue, 16 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391952</guid>        </item>
        <item>
            <title>Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial</title>
            <link>http://www.medworm.com/index.php?rid=5134725&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003823%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The very intense RT-CT schedule was more efficient on disease control, but was also more toxic than accelerated RT alone, pointing out that there was no clear improvement of the therapeutic index. This study shows the limits of dose-intensification, with regard to concomitant RT-CT. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134725</comments>
            <pubDate>Tue, 09 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134725</guid>        </item>
        <item>
            <title>Acquisition of MV-scatter-free kilovoltage CBCT images during RapidArc™ or VMAT</title>
            <link>http://www.medworm.com/index.php?rid=5134738&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003860%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: We have developed a method to acquire MV-scatter-free kV CBCT images concomitant with the delivery of RapidArc treatment. Engineering development is necessary to improve the process, e.g. by synchronization of the MV and kV beams. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134738</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134738</guid>        </item>
        <item>
            <title>Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours</title>
            <link>http://www.medworm.com/index.php?rid=5134737&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003744%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: Micromilieu-dependent quantification of γH2AX after irradiation in vivo and correlation with local tumour control.Materials and methods: Local tumour control was evaluated after irradiation of FaDu and SKX xenografts with ambient single doses. γH2AX foci were quantified in perfused and unperfused regions after different irradiation doses and at different time points.Results: The TCD50 of FaDu was 2-times higher compared to SKX (28.0Gy [95% C.I. 24.6; 31.3Gy] for FaDu; 14.9Gy [10.9; 18.9] for SKX, p (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134737</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134737</guid>        </item>
        <item>
            <title>Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer</title>
            <link>http://www.medworm.com/index.php?rid=5134733&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003884%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: To analyse the overall clinical outcome and benefits by applying protocol based image guided adaptive brachytherapy combined with 3D conformal external beam radiotherapy (EBRT)±chemotherapy (ChT).Methods: Treatment schedule was EBRT with 45–50.4Gy±concomitant cisplatin chemotherapy plus 4×7Gy High Dose Rate (HDR) brachytherapy. Patients were treated in the “protocol period” (2001–2008) with the prospective application of the High Risk CTV concept (D90) and dose volume constraints for organs at risk including biological modelling. Dose volume adaptation was performed with the aim of dose escalation in large tumours (prescribed D90&gt;85Gy), often with inserting additional interstitial needles. Dose volume constraints (D2cc) were 70–75Gy for rectum and sigmoid...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134733</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134733</guid>        </item>
        <item>
            <title>Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial</title>
            <link>http://www.medworm.com/index.php?rid=5134731&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100380X%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: The EORTC 22881-10882 trial showed that for patients treated with breast conserving therapy (BCT), a 16Gy boost dose significantly improved local control, but increased the risk of breast fibrosis. A model to estimate the risk of ipsilateral breast relapse (IBR) already exists, but now a model has been developed which takes boost treatment into account and is based on centrally reviewed pathology.Materials and methods: A Cox model was developed based on central pathology review data and clinical data of 1603 patients from the EORTC 22881-10882 trial with a median follow-up of 11.5years. From a predefined set of variables, predictors with a maximal effect on 10-year IBR rate &gt;4% were retained in the model. Bootstrap re-sampling was used to assess model cali...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134731</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134731</guid>        </item>
        <item>
            <title>Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study</title>
            <link>http://www.medworm.com/index.php?rid=5134726&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003847%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Gefitinib was well-tolerated, but did not improve efficacy compared with placebo when given concomitantly with chemoradiotherapy, or as maintenance therapy alone. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134726</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134726</guid>        </item>
        <item>
            <title>Advancing radiation oncology through scientific publication – 100 volumes of Radiotherapy and Oncology</title>
            <link>http://www.medworm.com/index.php?rid=5134716&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003872%2Fabstract%3Frss%3Dyes</link>
            <description>ESTRO, the European Society for Therapeutic Radiation Oncology, or with its new name European Society for Radiation Oncology, is a scientific society. It means that the prime aim of ESTRO is to bring to bring people together on an individual basis who have a common interest in improving the scientific conduct of radiotherapy and cancer treatment in Europe by ensuring that proper radiotherapy is available in the multidisciplinary treatment of cancer and applied with the right indication and with the most optimal technique. One of the main aims of this endeavour was to create a platform for scientific exchange through meetings and through the establishment of a scientific journal . Thus Radiotherapy and Oncology was launched shortly after the foundation of ESTRO and has become the society’...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134716</comments>
            <pubDate>Sun, 07 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134716</guid>        </item>
        <item>
            <title>Important ESTRO dates</title>
            <link>http://www.medworm.com/index.php?rid=5187221&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004725%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187221</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5187221</guid>        </item>
        <item>
            <title>Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer – Is it still an issue?</title>
            <link>http://www.medworm.com/index.php?rid=5187189&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS016781401100449X%2Fabstract%3Frss%3Dyes</link>
            <description>This study was the first large-scale epidemiological study on irradiated breast cancer patients, and it prompted valuable research into the causes of this unexpected finding. The study was based on almost 8000 breast cancer patients included in eight clinical trials commenced before 1975 where patients after mastectomy were randomised to ± adjuvant radiotherapy. A later report from Cuzick et al. on the cause-specific mortality in these trials identified heart mortality as the primary reason for the excess mortality . Since these important reports from Cuzick et al. the heart has been considered an organ at risk (OAR) when planning adjuvant radiotherapy for breast cancer. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187189</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5187189</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5187188&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004701%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187188</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5187188</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5187187&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011004695%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5187187</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5187187</guid>        </item>
        <item>
            <title>Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: A cohort study based on 994 patients</title>
            <link>http://www.medworm.com/index.php?rid=5134732&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003343%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: For patients with a laryngeal carcinoma treated with RT alone, we have developed visual, easy-to-use nomograms for the prediction of overall survival and primary local control. These models have been successfully validated in four external centers. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134732</comments>
            <pubDate>Sun, 24 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134732</guid>        </item>
        <item>
            <title>Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=5434176&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003410%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: To evaluate whether FDG-PET performed for radiotherapy (RT) planning can detect disease progression, compared with staging PET.Materials and methods: Twenty-six patients with newly-diagnosed non-small-cell lung cancer underwent planning PET-CT for curative RT within 8weeks (mean: 33±14days) of staging PET-CT. Progressive disease (PD) was defined as &gt;25% increase in tumour size (transaxial) or volume, as delineated by SUV threshold of 2.5, or new sites (SUV&gt;2.5).Results: The planning PET detected PD in 16 patients (61%), compared to four patients (15%) by CT component of PET-CT. The mean scan interval was longer in patients with progression: 40±12days, compared to 22±11days without progression. Planning PET detected PD in 13/17 (76%), 12/14 (86%) and 7/7...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434176</comments>
            <pubDate>Fri, 22 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434176</guid>        </item>
        <item>
            <title>Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: A prospective study</title>
            <link>http://www.medworm.com/index.php?rid=5134736&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003392%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background and purpose: To characterise the incidence, pattern and severity of post cranial radiotherapy somnolence and to identify factors predictive of frequency and severity.Materials and methods: Seventy consecutive patients receiving radical cranial irradiation were prospectively assessed for somnolence at baseline, during and up to 10weeks following radiotherapy using five variables scored on a visual analogue scale (VAS) and the Littman scale. Fatigue was measured using the FACT-G score and quality of life using the EORTC QLQC30+3 with the brain tumour module questionnaire.Results: Ninety percent of patients experienced ⩾grade 1 somnolence (Littman score) and this correlated with VAS scores (r=0.456, p (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134736</comments>
            <pubDate>Thu, 21 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134736</guid>        </item>
        <item>
            <title>Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery</title>
            <link>http://www.medworm.com/index.php?rid=5434168&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003409%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Similar OS outcomes are achieved with surgery or SBRT for stage I NSCLC in elderly patients. Comorbidity data and outcomes from centralized surgical programs are needed for more robust conclusions. (Source: Radiotherapy and Oncology)</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5434168</comments>
            <pubDate>Wed, 20 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5434168</guid>        </item>
        <item>
            <title>Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5391971&amp;cid=s_38642_37_f&amp;fid=38642&amp;url=http%3A%2F%2Fwww.thegreenjournal.com%2Farticle%2FPIIS0167814011003331%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Background: Overexpression of EGFR correlates with decreased survival after radiotherapy in head and neck squamous cell carcinoma (HNSCC). However, the contribution of the activated form, pEGFR, and its downstream signaling (PI3-K/AKT) pathway is not clear yet.Methods: Fifty-eight patients with HNSCC were included in the study. pEGFR, pAKT, hypoxia, and vessels were visualized using immunohistochemistry. Fractions (defined as the tumor area positive for the respective markers relative to the total tumor area) were calculated by automated image analysis and related to clinical outcome.Results: Both pEGFR (median 0.6%, range 0–34%) and pAKT (median 1.8%, range 0–16%) expression differed between tumors. Also, a large variation in hypoxia was found (median pimonidazole fraction 3...</description>
            <author>Radiotherapy and Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5391971</comments>
            <pubDate>Wed, 20 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5391971</guid>        </item>
    </channel>
</rss>

